TherapeuticsMD, Inc. (TXMD) Ownership

NASDAQ: TXMDTop holders, insider trades and short interest.

TXMD ownership summary

as of October 18, 2026
Institutions
31.7%
of shares outstanding
Insiders
9.04%
of shares outstanding
Shares outstanding
11.6M
Float
9.5M
shares available to trade
Short interest
0.28%
24K shares short
Days to cover
1.15
short interest down 10.5% vs prior month
  • Institutions 31.73%
  • Insiders 9.04%
  • Other investors 59.23%

TXMD top institutional holders

20 largest
TherapeuticsMD, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Rubric Capital Management LP10.30%1.2M$2.3M—June 30, 2026
2Clearline Capital LP5.49%635K$1.2M—June 30, 2026
3Vanguard Capital Management, LLC3.06%354K$672,024—June 30, 2026
4Tejara Capital Ltd2.98%344K$654,516−1,370 (−0.4%)June 30, 2026
5ADAR1 Capital Management LLC2.96%342K$650,649+133,237 (+63.7%)June 30, 2026
6Renaissance Technologies Corp1.27%147K$278,538+399 (+0.3%)June 30, 2026
7Morgan Stanley - Brokerage Accounts1.12%129K$245,512—June 30, 2026
8BlackRock Inc0.99%115K$218,776—June 30, 2026
9Geode Capital Management, LLC0.91%106K$201,113−3,968 (−3.6%)June 30, 2026
10Citadel Advisors Llc0.74%86K$163,580+17,781 (+26.0%)June 30, 2026
11Vanguard Fiduciary Trust Co0.55%64K$121,279—June 30, 2026
12State Street Corp0.26%30K$57,190—June 30, 2026
13XTX Topco Ltd0.18%21K$40,367−6,241 (−22.7%)June 30, 2026
14Dimensional Fund Advisors, Inc.0.17%20K$37,466+9,013 (+84.2%)June 30, 2026
15Northern Trust Corp0.16%19K$35,256+2,463 (+15.3%)June 30, 2026
16Bridgeway Capital Management, LLC0.15%17K$32,300—June 30, 2026
17Advisor Group Holdings, Inc.0.13%15K$28,876+15,045 (+9,833.3%)June 30, 2026
18HRT FINANCIAL LLC0.13%15K$27,981+14,727 (0.0%)June 30, 2026
19Vanguard Global Advisers, LLC0.04%4,937$9,380—June 30, 2026
20UBS Group AG0.04%4,660$8,854+4,329 (+1,307.9%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 8 holders added 197K shares and 3 cut 12K.

TXMD top mutual fund and ETF holders

16 largest
TherapeuticsMD, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest2.11%244K$464,202—August 31, 2026
2Fidelity Extended Market Index0.52%61K$115,294−326 (−0.5%)August 31, 2026
3EA Bridgeway Ultra-Small Company Mkt ETF0.14%17K$31,848—September 30, 2026
4Fidelity Series Total Market Index0.13%15K$29,108—August 31, 2026
5Fidelity Total Market Index0.13%15K$28,186—August 31, 2026
6DFA US Vector Equity I0.04%5,063$9,620+5,063 (0.0%)August 31, 2026
7Vanguard U.S. Eq Idx £ Acc0.04%4,937$9,380—August 31, 2026
8Dimensional US Core Equity 2 ETF0.04%4,826$9,169—September 30, 2026
9DFA US Core Equity Class F0.04%4,555$8,654—July 31, 2026
10Dimensional US Sustainability Core 1 ETF0.03%3,612$6,863—September 30, 2026
11Gabelli ABC I0.03%3,600$6,840—June 30, 2026
12Dimensional US Core Equity 1 ETF0.03%3,076$5,844—September 24, 2026
13Gabelli Entpr Mergers & Acquisitions Y0.01%1,000$1,900—July 31, 2026
14BlackRock Diversified Equity Alpha Inst0.01%745$1,416—July 31, 2026
15DFA US Vector Equity Class F0.01%642$1,220—July 31, 2026
16Guggenheim Active Allocation Fund<0.01%92$175+46 (+100.0%)May 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

TXMD insider transactions

latest 1
TherapeuticsMD, Inc. insider transactions
DateNameTransactionPriceSharesValue
2025-12-23Tommy G ThompsonBuy$1.678,400$14,028

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

TXMD shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns TXMD

Institutional investors own 31.7% of TherapeuticsMD's shares and insiders 9.04%. The largest holder is Rubric Capital Management LP with 10.30% of the shares (1.2M), as of June 30, 2026. Among the top 20 institutions, 8 added shares and 3 reduced their stake in the latest filings. Short interest is 0.28% of the float, or 1.15 days of average trading volume. The share count rose 270.7% since 2014.

Related: TXMD key metrics. See the TXMD stock overview for the latest quote and news.

TXMD ownership FAQ

Who owns the most TherapeuticsMD stock?

The largest shareholders of TherapeuticsMD are Rubric Capital Management LP (10.30%), Clearline Capital LP (5.49%), Vanguard Capital Management, LLC (3.06%), Tejara Capital Ltd (2.98%), ADAR1 Capital Management LLC (2.96%).

What percentage of TherapeuticsMD is owned by institutions?

Institutions hold 31.7% of TherapeuticsMD's shares outstanding; insiders hold 9.04%.

Which funds own TherapeuticsMD?

The largest fund holders of TherapeuticsMD are Vanguard MStar Total Stk Mkt Idx Invest (2.11%), Fidelity Extended Market Index (0.52%), EA Bridgeway Ultra-Small Company Mkt ETF (0.14%), Fidelity Series Total Market Index (0.13%), Fidelity Total Market Index (0.13%).

What is TherapeuticsMD's short interest?

24K shares of TherapeuticsMD were sold short, 0.28% of the float; at the average daily volume it would take 1.15 days to cover.

Are insiders buying or selling TherapeuticsMD?

Of the latest 1 reported insider transactions in TherapeuticsMD (since December 23, 2025), 1 were purchases and 0 were sales.

How many shares of TherapeuticsMD are outstanding?

TherapeuticsMD has 11.6M shares outstanding, of which 9.5M are in the public float.

Drug Manufacturers - Specialty & Generic: ownership